Bone marrow reticulin and collagen content in patients with adult chronic immune thrombocytopenic purpura: A Danish nationwide study

American Journal of Hematology

Volumn 85, Issue 12, 2010, Pages 930-934

  Ettrup, Marianne Schmidt ^a,b   Jensen, Annette Østergaard ^a   Engebjerg, Malene Cramer ^a   Farkas, Dóra Körmendiné ^a   Nørgaard, Mette ^a   Cha, Steven ^c   Zhao, Sean ^c   Johansen, Preben ^b   Sørensen, Henrik Toft ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGEN FIBER; RETICULIN;

ADULT; AGED; ARTICLE; BONE MARROW; BONE MARROW BIOPSY; CHRONIC DISEASE; CLINICAL FEATURE; DENMARK; FEMALE; FIBROSIS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MAJOR CLINICAL STUDY; MALE; MYELOFIBROSIS; PREVALENCE; PRIORITY JOURNAL; RATING SCALE; THIELE SCALE; THROMBOCYTE COUNT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BONE MARROW; COLLAGEN; DENMARK; FEMALE; FIBROSIS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RETICULIN; RETROSPECTIVE STUDIES; SEX FACTORS; YOUNG ADULT;

EID: 78649517616     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21885     Document Type: Article

References (20)

1. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: Report from an international working group. Blood 2009; 113: 2386-2393.
2. Gernsheimer T. Epidemiology and pathophysiology of immune thrombocytopenic purpura. Eur J Haematol Suppl 2008; 80: 3-8.
3. McMillan R. The pathogenesis of chronic immune thrombocytopenic purpura. Semin Hematol 2007, 44: S3-S11.
4. Wang L, Li Y, Hou M. Idiopathic thrombocytopenic purpura and dysmegakaryocytopoiesis. Crit Rev Oncol Hematol 2007; 64: 83-89.
5. Schmitt A, Jouault H, Guichard J, et al. Pathologic interaction between megakaryocytes and polymorphonuclear leukocytes in myelofibrosis. Blood 2000; 96: 1342-1347.
6. Bauermeister DE. Quantitation of bone marrow reticulin-A normal range. Am J Clin Pathol 1971; 56: 24-31.
7. Mufti G, Bagg A, Hasserjian RP, et al. Bone marrow reticulin in patients with immune thrombocytopenic purpura. Presented at the 48th Annual Meeting of the American Society of Hematology, Orlando, Florida, December 9-12, 2006.
8. Frank L. Epidemiology. When an entire country is a cohort. Science 2000; 287: 2398-2399.
9. Andersen TF, Madsen M, Jorgensen J, et al. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999; 46: 263-268.
10. The Systematized Nomenclature of Medicine. Available at
11. Thiele J, Kvasnicka HM, Facchetti F, et al. European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica 2005; 90: 1128-1132.
12. Frederiksen H, Schmidt K. The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood 1999; 94: 909-913.
13. Neylon AJ, Saunders PW, Howard MR, et al. Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: A prospective study of a population-based cohort of 245 patients. Br J Haematol 2003; 122: 966-974.
14. Saleh MN, Fisher M, Grotzinger KM. Analysis of the impact and burden of illness of adult chronic ITP in the US. Curr Med Res Opin 2009; 25: 2961-2969.
15. Thiele J, Kvasnicka HM. Myelofibrosis-What's in a name? Consensus on definition and EUMNET grading. Pathobiology 2007; 74: 89-96.
16. Tefferi A, Barosi G, Mesa RA, et al. International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for myelofibrosis research and treatment (IWG-MRT). Blood 2006; 108: 1497-1503.
17. Barosi G, Bordessoule D, Briere J, et al. Response criteria for myelofibrosis with myeloid metaplasia: Results of an initiative of the European myelofibrosis network (EUMNET). Blood 2005; 106: 2849-2853.
18. Ershler WB. The influence of an aging immune system on cancer incidence and progression. J Gerontol 1993; 48: B3-B7.
19. Pauklin S, Sernandez IV, Bachmann G, et al. Estrogen directly activates AID transcription and function. J Exp Med 2009; 206: 99-111.
20. McNutt LA, Wu C, Xue X, Hafner JP: Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 2003; 157: 940-943.